Zoulim, Fabien,
Fabien Zoulim médecin, chercheur
Esa, Fahmiruddin Bin
VIAF ID: 51967720 (Personal)
Permalink: http://viaf.org/viaf/51967720
Preferred Forms
- 100 1 _ ‡a Esa, Fahmiruddin Bin
- 100 0 _ ‡a Fabien Zoulim ‡c médecin, chercheur
- 200 _ | ‡a Zoulim ‡b Fabien
- 100 1 _ ‡a Zoulim, Fabien
- 100 1 _ ‡a Zoulim, Fabien
- 100 1 _ ‡a Zoulim, Fabien
-
-
-
- 100 1 _ ‡a Zoulim, Fabien,
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Alteration of p53 and NF-kB pathways by E7 protein from cutaneous Human Papillomavirus type 38 | |
Les ARNs secrétés par le virus de l'hépatite B sont associés aux vésicules extracellulaires dans le surnageant d'hépatocytes infectés. | |
Association of HBV variability and Aflatoxin B1 exposure on liver disease in West Africa | |
Characterization of adenovirus based Hepatitis B immunotherapeutic products and assessment of their ability to induce an immune response in mouse models. | |
Controlling the properties of OPEFB/PLA polymer composite by using Fe2O3 for microwave applications | |
Development of a new anti-cancer therapeutic approach in hepatocellular carcinoma : inhibition of the Frizzled-7 receptor. | |
Développement et évaluation de nouvelles stratégies pour le traitement des hépatites B chroniques, dans le modèle du canard de Pékin infecté par le DHBV | |
Dynamique adaptative des virus hautement variables à un nouvel environnement réplicatif | |
Étude de la variabilité génétique du Virus de l'Hépatite C (VHC) et de son implication dans la résistance aux traitements antiviraux | |
From the detection of cccDNA by new technologies to the proof concept of its therapeutic degradation in models of infection with the hepatitis B virus. | |
From the screening of antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus (HBV), towards the NF-κB-dependent antiviral mechanism of interleukin-1β. | |
GENOTYPAGE ET DETECTION DES MUTATIONS PRE-CORE DU GENOME DU VIRUS DE L'HEPATITE B : CORRELATION AVEC LA PERSISTANCE VIRALE ET LA SEVERITE DE LA MALADIE HEPATIQUE | |
Hépatites virales B et C | |
Hepatitis B virus in human diseases, 2016: | |
The histone chaperone HIRA is crucial for the early establishment of hepatitis B virus minichromosome | |
Identification of new mechanisms of carcinogenesis and new prognostic biomarkers in hepatocellular tumors. | |
Impact de l'infection par le virus de l'hépatite C sur les mitochondries. | |
Implication du gène core dans l'accumulation de l'ADN circulaire clos de façon covalente du virus de l'hépatite B | |
Interaction between macrophages, hepatocytes and hepatitis B virus : from reprogramming of macrophages phenotypes towards establishment and maintenance of the infection | |
Intéractions entre le virus de l'hépatite B et la réponse immunitaire innée de l'hote in vivo au cours de l'histoire naturelle de l'infection | |
Mécanismes de l'inhibition de la transcriptase inverse des hépadnavirus et de l'élimination virale induites par de nouveaux analogues de nucléosides et de nouvelles stratégies thérapeutiques, dans les modèles animaux de l'hépatite B | |
Modelling the effect of new anti-HBV drugs using animal and clinical data. | |
Netrin-1 and its receptor UNC5A during endoplasmic reticulum stress and inflammation in the liver. | |
Nétrine-1 et neurones dans le carcinome hépatocellulaire. | |
La nétrine-1 et son récepteur UNC5A en contexte de stress réticulaire et d'inflammation hépatiques | |
Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance. | |
Optimisation du traitement anti-VHC : place des dosages pharmacologiques et des cinétiques virales à l'ère des antiviraux directs | |
Pas de titre traduit. | |
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion. | |
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. | |
Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications | |
Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection. | |
Polo-like-kinase 1 is a proviral host-factor for hepatitis B virus replication | |
Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B | |
PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis B | |
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study. | |
[Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study] | |
Progress in DNA vaccine for prophylaxis and therapy of hepatitis B. | |
La protéine Core du virus de l'hépatite B est le déterminant majeur responsable de l'inhibition précoce de la réponse IFN dans les hépatocytes | |
Quantification of HBsAg in nucleos | |
A quasi-monoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus. | |
Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus | |
Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus | |
Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection. | |
Reprogrammation du métabolisme de la glutamine par le virus de l'hépatite C. | |
[Results of a satisfaction survey carried out among patients living with the virus of human immunodeficiency (HIV) following therapeutic education sessions] | |
Rôle physiopathologique de la voie vésiculaire de la production hépatique de glucose : implication de la cavéoline-1 dans le transport de la glucose-6-phosphatase | |
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial | |
SIGNIFICATION DE L'EXPRESSION DES PROTEINES PRE-S1 DANS LE SERUM ET LES CELLULES MONONUCLEEES DU SANG AU COURS DES INFECTIONS CHRONIQUES DUES AU VIRUS DE L'HEPATITE B | |
Study of HBV replication and intracellular response to viral infection. | |
Study of the complete amplified and single-fragment sequenced genomes of circulating hepatitis B and Delta viruses in infected patients : development and applications. | |
STUDY OF THE REPLICATION CYCLE OF HEPADNAVIRUSES AND THEIR VIRAL PROTEINS PRE-S, P AND X. | |
Study of the transcriptome of human endogenous retroviruses and functional implications : applications to the search for diagnostic markers of cancers. | |
Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure. | |
[Towards new therapeutic concepts to fight against chronic hepatitis B] | |
Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity. | |
[Treatment of hepatitis C: decisive therapeutic advances] | |
Utilisation du modèle de l'hépatite B du canard pour la détermination de l'activité antivirale du L-FMAU et l'étude de la biologie de mutants de résistance à la lamivudine | |
Validation of the INNO-LiPA HBV DR assay | |
Variability in the precore and core promoter regions of HBV strains in Morocco: characterization and impact on liver disease progression | |
Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication. | |
Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells. | |
Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection | |
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis. | |
Virology of hepatitis B | |
Virus de l'Hépatite B et transcription cellulaire : impact de la protéine HBx et de ses interactions avec les ARNs non-codants | |
ウイルス性肝炎 |